+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Nuclear Medicine Market by Product Type (Diagnostic Radiopharmaceuticals, Therapeutic Nuclear Medicine), Mode Of Administration (Intravenous Injection, Oral Ingestion), Usage, Application, End Users - Global Forecast 2025-2030- Product Image
Nuclear Medicine Market by Product Type (Diagnostic Radiopharmaceuticals, Therapeutic Nuclear Medicine), Mode Of Administration (Intravenous Injection, Oral Ingestion), Usage, Application, End Users - Global Forecast 2025-2030- Product Image
Sale

Nuclear Medicine Market by Product Type (Diagnostic Radiopharmaceuticals, Therapeutic Nuclear Medicine), Mode Of Administration (Intravenous Injection, Oral Ingestion), Usage, Application, End Users - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 181 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 5206422
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The nuclear medicine market is at a pivotal stage of evolution, driven by rapid innovation in imaging techniques and radiopharmaceutical therapies. With expanding applications across diagnostic and therapeutic areas, the industry is responding to rising clinical demand and increasing expectations from health systems worldwide.

Market Snapshot: Nuclear Medicine Market Trends and Growth

The Nuclear Medicine Market grew from USD 14.60 billion in 2024 to USD 16.05 billion in 2025. It is expected to continue growing at a CAGR of 10.80%, reaching USD 27.04 billion by 2030.

Strong market momentum is fueled by converging advancements in targeted radiopharmaceuticals and state-of-the-art imaging systems. Growth reflects a transition toward precision medicine models as hospitals, diagnostic centers, and research institutions align investments with evolving clinical needs.

Scope & Segmentation

  • Product Types: Diagnostic radiopharmaceuticals (Positron Emission Tomography [PET] isotopes, Single Photon Emission Computed Tomography [SPECT] isotopes); Therapeutic nuclear medicine (brachytherapy isotopes such as cesium-131, iodine-125, iridium-192, palladium-103, and radiopharmaceutical therapy with alpha and beta emitters).
  • Modes of Administration: Intravenous injection and oral ingestion.
  • Usage Scenarios: Diagnostic procedures (PET and SPECT scanners, analog and digital PET systems), therapeutic procedures (targeted radiotherapy for malignant conditions).
  • Applications: Cardiology, endocrinology, gastroenterology, neurology, oncology, orthopedics, pulmonology.
  • End Users: Academic and research institutes, diagnostic centers, hospitals (government and private facilities).
  • Regions Covered: Americas (including United States, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (including United Kingdom, Germany, France, Russia, Italy, Spain, United Arab Emirates, Saudi Arabia, South Africa, and more), Asia-Pacific (including China, India, Japan, Australia, South Korea, Indonesia, Thailand, Philippines, Malaysia, Singapore, Vietnam, and Taiwan).
  • Key Technologies: PET and SPECT imaging modalities, AI-driven interpretation, digital imaging platforms, targeted radiopharmaceutical and theranostic agents.

Key Takeaways for Decision-Makers

  • Industry-wide collaboration is accelerating the development and adoption of innovative isotopes and next-generation scanners, supporting advances in both diagnostics and therapy.
  • The integration of artificial intelligence in workflow optimization is enhancing image reconstruction, anomaly detection, and treatment monitoring, positioning providers for improved clinical efficiency.
  • As regulatory requirements and healthcare payer criteria evolve, organizations are adopting robust compliance strategies and digital infrastructure to ensure continued market access.
  • Strategic partnerships across academic, biotech, and established industry players are catalyzing product development and market entry in high-potential geographies.
  • Organizations are expanding domestic and regional supply chains to mitigate disruptions caused by tariff and regulatory adjustments, strengthening operational resilience and quality assurance.
  • Segmentation analysis reveals diverse clinical demand, allowing companies to prioritize targeted innovations and offer differentiated solutions across specialized clinical and geographic markets.

Tariff Impacts Reshaping Supply Chain Strategies

Significant tariff adjustments in the United States for 2025 are altering procurement costs and supply chain stability in the nuclear medicine sector. Increased duties on isotopes and imaging components are prompting companies to reexamine sourcing, pursue alternative production channels, and invest in domestic capacity. These measures are coupled with enhanced compliance initiatives to maintain uninterrupted access to critical diagnostics and therapies. Stakeholders are focusing on operational efficiency and inventory management to address cost and logistical complexity.

Methodology & Data Sources

This market research report integrates primary data from expert interviews with secondary sources, including peer-reviewed journals, clinical trial registries, financial reports, and proprietary industry databases. Validation protocols ensure accuracy through triangulation and external advisory review, supporting high-integrity, actionable insights.

Nuclear Medicine Market: Why This Report Matters

  • Provides concise, validated intelligence to support strategic investments in innovation and expansion.
  • Delivers granular segmentation and regional analysis, enabling data-driven prioritization across product, application, and geographic opportunities.
  • Highlights emerging risks and operational considerations, equipping leaders to ensure compliance, resilience, and sustained competitive advantage.

Conclusion

The nuclear medicine sector is transforming clinical and operational pathways through targeted innovation, smart partnerships, and sophisticated supply chain strategies. Industry leaders who leverage these insights are positioned to drive value, accelerate growth, and navigate evolving regulatory and market dynamics effectively.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Expansion of fluorine-18 based radiotracers for targeted PET imaging in oncology
5.2. Integration of artificial intelligence and machine learning for automated PET/CT image analysis and diagnostic accuracy
5.3. Growth of theranostic pairs combining diagnostic imaging isotopes like gallium-68 with therapeutic isotopes like lutetium-177 for personalized cancer treatment
5.4. Increasing adoption of total-body PET scanners to improve sensitivity and reduce radiation dose in whole-body imaging studies
5.5. Advancements in cyclotron and radiopharmacy infrastructure to support local production of short-lived radionuclides and reduce supply chain constraints
5.6. Regulatory progress and approvals for novel alpha-emitting radionuclide therapies such as actinium-225 based treatments for prostate cancer
5.7. Implementation of cloud-based digital platforms for secure sharing and collaboration of nuclear imaging data across multi-center trials
5.8. Development of cost-effective compact cyclotrons to decentralize production of PET tracers and expand access in community hospitals
5.9. Emergence of novel radioimmunoconjugates targeting PSMA and HER2 for precision nuclear medicine applications in metastatic disease
5.10. Application of deep learning algorithms to optimize radiopharmaceutical synthesis protocols and enhance yield consistency
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Nuclear Medicine Market, by Product Type
8.1. Introduction
8.2. Diagnostic Radiopharmaceuticals
8.2.1. Positron Emission Tomography (PET) Isotopes
8.2.2. Single Photon Emission Computed Tomography (SPECT) Isotopes
8.3. Therapeutic Nuclear Medicine
8.3.1. Brachytherapy Isotopes
8.3.1.1. Cesium-131
8.3.1.2. Iodine-125
8.3.1.3. Iridium-192
8.3.1.4. Palladium-103
8.3.2. Radiopharmaceutical Therapy
8.3.2.1. Alpha Emitters
8.3.2.2. Beta Emitters
9. Nuclear Medicine Market, by Mode Of Administration
9.1. Introduction
9.2. Intravenous Injection
9.3. Oral Ingestion
10. Nuclear Medicine Market, by Usage
10.1. Introduction
10.2. Diagnostic Procedure
10.2.1. PET Scanners
10.2.1.1. Analog PET
10.2.1.2. Digital PET
10.2.2. SPECT Scanners
10.3. Therapeutic Procedure
11. Nuclear Medicine Market, by Application
11.1. Introduction
11.2. Cardiology
11.3. Endocrinology
11.4. Gastroenterology
11.5. Neurology
11.6. Oncology
11.7. Orthopedics
11.8. Pulmonology
12. Nuclear Medicine Market, by End Users
12.1. Introduction
12.2. Academic & Research Institutes
12.3. Diagnostic Centers
12.4. Hospitals
12.4.1. Government Hospitals
12.4.2. Private Hospitals
13. Americas Nuclear Medicine Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Nuclear Medicine Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Nuclear Medicine Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. 3B Pharmaceuticals GmbH
16.3.2. Actinium Pharmaceuticals, Inc.
16.3.3. B J Madan & Co.
16.3.4. Bayer AG
16.3.5. Bracco S.p.A.
16.3.6. BWX Technologies, Inc.
16.3.7. Clarity Pharmaceuticals
16.3.8. Curium
16.3.9. Eli Lilly and Company
16.3.10. GE HealthCare
16.3.11. IBA
16.3.12. Institute of Isotopes Co., Ltd
16.3.13. Isotopia Molecular Imaging Ltd.
16.3.14. Jubilant Pharma Limited
16.3.15. Lantheus Holdings, Inc.
16.3.16. Medi-Radiopharma Co., Ltd.
16.3.17. Nordion
16.3.18. Northstar Medical Technologies LLC
16.3.19. Novartis AG
16.3.20. Nusano, Inc.
16.3.21. PeptiDream Inc.
16.3.22. Radiopharm Theranostics Limited
16.3.23. SHINE Technologies, LLC
16.3.24. Siemens Healthineers AG
16.3.25. Sinotau Pharmaceuticals Group
16.3.26. South African Nuclear Energy Corporation
16.3.27. State Atomic Energy Corporation Rosatom
16.3.28. Thor Medical AS by Nordic Nanovector ASA
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. NUCLEAR MEDICINE MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL NUCLEAR MEDICINE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY MODE OF ADMINISTRATION, 2024 VS 2030 (%)
FIGURE 8. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY MODE OF ADMINISTRATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY USAGE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY USAGE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 12. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY END USERS, 2024 VS 2030 (%)
FIGURE 14. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY END USERS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS NUCLEAR MEDICINE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS NUCLEAR MEDICINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA NUCLEAR MEDICINE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA NUCLEAR MEDICINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC NUCLEAR MEDICINE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC NUCLEAR MEDICINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. NUCLEAR MEDICINE MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. NUCLEAR MEDICINE MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. NUCLEAR MEDICINE MARKET: RESEARCHAI
FIGURE 26. NUCLEAR MEDICINE MARKET: RESEARCHSTATISTICS
FIGURE 27. NUCLEAR MEDICINE MARKET: RESEARCHCONTACTS
FIGURE 28. NUCLEAR MEDICINE MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. NUCLEAR MEDICINE MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL NUCLEAR MEDICINE MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL NUCLEAR MEDICINE MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC RADIOPHARMACEUTICALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC RADIOPHARMACEUTICALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY (PET) ISOTOPES, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY (PET) ISOTOPES, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY (SPECT) ISOTOPES, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY (SPECT) ISOTOPES, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC RADIOPHARMACEUTICALS, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC RADIOPHARMACEUTICALS, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC NUCLEAR MEDICINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC NUCLEAR MEDICINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY BRACHYTHERAPY ISOTOPES, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY BRACHYTHERAPY ISOTOPES, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY CESIUM-131, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY CESIUM-131, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY IODINE-125, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY IODINE-125, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY IRIDIUM-192, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY IRIDIUM-192, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY PALLADIUM-103, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY PALLADIUM-103, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY BRACHYTHERAPY ISOTOPES, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY BRACHYTHERAPY ISOTOPES, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY RADIOPHARMACEUTICAL THERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY RADIOPHARMACEUTICAL THERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY ALPHA EMITTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY ALPHA EMITTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY BETA EMITTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY BETA EMITTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY RADIOPHARMACEUTICAL THERAPY, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY RADIOPHARMACEUTICAL THERAPY, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC NUCLEAR MEDICINE, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC NUCLEAR MEDICINE, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY MODE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY INTRAVENOUS INJECTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY INTRAVENOUS INJECTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY ORAL INGESTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY ORAL INGESTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY USAGE, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY USAGE, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC PROCEDURE, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC PROCEDURE, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY PET SCANNERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY PET SCANNERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY ANALOG PET, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY ANALOG PET, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY DIGITAL PET, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY DIGITAL PET, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY PET SCANNERS, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY PET SCANNERS, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY SPECT SCANNERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY SPECT SCANNERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC PROCEDURE, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC PROCEDURE, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC PROCEDURE, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC PROCEDURE, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY CARDIOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY CARDIOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY ENDOCRINOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY ENDOCRINOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY GASTROENTEROLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY GASTROENTEROLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY NEUROLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY ONCOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY ORTHOPEDICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY ORTHOPEDICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY PULMONOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY PULMONOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY END USERS, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY END USERS, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY GOVERNMENT HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY GOVERNMENT HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 95. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 96. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 97. AMERICAS NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 98. AMERICAS NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 99. AMERICAS NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC RADIOPHARMACEUTICALS, 2018-2024 (USD MILLION)
TABLE 100. AMERICAS NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC RADIOPHARMACEUTICALS, 2025-2030 (USD MILLION)
TABLE 101. AMERICAS NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC NUCLEAR MEDICINE, 2018-2024 (USD MILLION)
TABLE 102. AMERICAS NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC NUCLEAR MEDICINE, 2025-2030 (USD MILLION)
TABLE 103. AMERICAS NUCLEAR MEDICINE MARKET SIZE, BY BRACHYTHERAPY ISOTOPES, 2018-2024 (USD MILLION)
TABLE 104. AMERICAS NUCLEAR MEDICINE MARKET SIZE, BY BRACHYTHERAPY ISOTOPES, 2025-2030 (USD MILLION)
TABLE 105. AMERICAS NUCLEAR MEDICINE MARKET SIZE, BY RADIOPHARMACEUTICAL THERAPY, 2018-2024 (USD MILLION)
TABLE 106. AMERICAS NUCLEAR MEDICINE MARKET SIZE, BY RADIOPHARMACEUTICAL THERAPY, 2025-2030 (USD MILLION)
TABLE 107. AMERICAS NUCLEAR MEDICINE MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 108. AMERICAS NUCLEAR MEDICINE MARKET SIZE, BY MODE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 109. AMERICAS NUCLEAR MEDICINE MARKET SIZE, BY USAGE, 2018-2024 (USD MILLION)
TABLE 110. AMERICAS NUCLEAR MEDICINE MARKET SIZE, BY USAGE, 2025-2030 (USD MILLION)
TABLE 111. AMERICAS NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC PROCEDURE, 2018-2024 (USD MILLION)
TABLE 112. AMERICAS NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC PROCEDURE, 2025-2030 (USD MILLION)
TABLE 113. AMERICAS NUCLEAR MEDICINE MARKET SIZE, BY PET SCANNERS, 2018-2024 (USD MILLION)
TABLE 114. AMERICAS NUCLEAR MEDICINE MARKET SIZE, BY PET SCANNERS, 2025-2030 (USD MILLION)
TABLE 115. AMERICAS NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 116. AMERICAS NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 117. AMERICAS NUCLEAR MEDICINE MARKET SIZE, BY END USERS, 2018-2024 (USD MILLION)
TABLE 118. AMERICAS NUCLEAR MEDICINE MARKET SIZE, BY END USERS, 2025-2030 (USD MILLION)
TABLE 119. AMERICAS NUCLEAR MEDICINE MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 120. AMERICAS NUCLEAR MEDICINE MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 121. AMERICAS NUCLEAR MEDICINE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 122. AMERICAS NUCLEAR MEDICINE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 123. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 124. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 125. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC RADIOPHARMACEUTICALS, 2018-2024 (USD MILLION)
TABLE 126. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC RADIOPHARMACEUTICALS, 2025-2030 (USD MILLION)
TABLE 127. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC NUCLEAR MEDICINE, 2018-2024 (USD MILLION)
TABLE 128. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC NUCLEAR MEDICINE, 2025-2030 (USD MILLION)
TABLE 129. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY BRACHYTHERAPY ISOTOPES, 2018-2024 (USD MILLION)
TABLE 130. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY BRACHYTHERAPY ISOTOPES, 2025-2030 (USD MILLION)
TABLE 131. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY RADIOPHARMACEUTICAL THERAPY, 2018-2024 (USD MILLION)
TABLE 132. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY RADIOPHARMACEUTICAL THERAPY, 2025-2030 (USD MILLION)
TABLE 133. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 134. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY MODE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 135. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY USAGE, 2018-2024 (USD MILLION)
TABLE 136. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY USAGE, 2025-2030 (USD MILLION)
TABLE 137. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC PROCEDURE, 2018-2024 (USD MILLION)
TABLE 138. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC PROCEDURE, 2025-2030 (USD MILLION)
TABLE 139. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY PET SCANNERS, 2018-2024 (USD MILLION)
TABLE 140. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY PET SCANNERS, 2025-2030 (USD MILLION)
TABLE 141. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 142. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 143. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY END USERS, 2018-2024 (USD MILLION)
TABLE 144. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY END USERS, 2025-2030 (USD MILLION)
TABLE 145. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 146. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 147. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 148. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 149. CANADA NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 150. CANADA NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 151. CANADA NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC RADIOPHARMACEUTICALS, 2018-2024 (USD MILLION)
TABLE 152. CANADA NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC RADIOPHARMACEUTICALS, 2025-2030 (USD MILLION)
TABLE 153. CANADA NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC NUCLEAR MEDICINE, 2018-2024 (USD MILLION)
TABLE 154. CANADA NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC NUCLEAR MEDICINE, 2025-2030 (USD MILLION)
TABLE 155. CANADA NUCLEAR MEDICINE MARKET SIZE, BY BRACHYTHERAPY ISOTOPES, 2018-2024 (USD MILLION)
TABLE 156. CANADA NUCLEAR MEDICINE MARKET SIZE, BY BRACHYTHERAPY ISOTOPES, 2025-2030 (USD MILLION)
TABLE 157. CANADA NUCLEAR MEDICINE MARKET SIZE, BY RADIOPHARMACEUTICAL THERAPY, 2018-2024 (USD MILLION)
TABLE 158. CANADA NUCLEAR MEDICINE MARKET SIZE, BY RADIOPHARMACEUTICAL THERAPY, 2025-2030 (USD MILLION)
TABLE 159. CANADA NUCLEAR MEDICINE MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 160. CANADA NUCLEAR MEDICINE MARKET SIZE, BY MODE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 161. CANADA NUCLEAR MEDICINE MARKET SIZE, BY USAGE, 2018-2024 (USD MILLION)
TABLE 162. CANADA NUCLEAR MEDICINE MARKET SIZE, BY USAGE, 2025-2030 (USD MILLION)
TABLE 163. CANADA NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC PROCEDURE, 2018-2024 (USD MILLION)
TABLE 164. CANADA NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC PROCEDURE, 2025-2030 (USD MILLION)
TABLE 165. CANADA NUCLEAR MEDICINE MARKET SIZE, BY PET SCANNERS, 2018-2024 (USD MILLION)
TABLE 166. CANADA NUCLEAR MEDICINE MARKET SIZE, BY PET SCANNERS, 2025-2030 (USD MILLION)
TABLE 167. CANADA NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 168. CANADA NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 169. CANADA NUCLEAR MEDICINE MARKET SIZE, BY END USERS, 2018-2024 (USD MILLION)
TABLE 170. CANADA NUCLEAR MEDICINE MARKET SIZE, BY END USERS, 2025-2030 (USD MILLION)
TABLE 171. CANADA NUCLEAR MEDICINE MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 172. CANADA NUCLEAR MEDICINE MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 173. MEXICO NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 174. MEXICO NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 175. MEXICO NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC RADIOPHARMACEUTICALS, 2018-2024 (USD MILLION)
TABLE 176. MEXICO NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC RADIOPHARMACEUTICALS, 2025-2030 (USD MILLION)
TABLE 177. MEXICO NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC NUCLEAR MEDICINE, 2018-2024 (USD MILLION)
TABLE 178. MEXICO NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC NUCLEAR MEDICINE, 2025-2030 (USD MILLION)
TABLE 179. MEXICO NUCLEAR MEDICINE MARKET SIZE, BY BRACHYTHERAPY ISOTOPES, 2018-2024 (USD MILLION)
TABLE 180. MEXICO NUCLEAR MEDICINE MARKET SIZE, BY BRACHYTHERAPY ISOTOPES, 2025-2030 (USD MILLION)
TABLE 181. MEXICO NUCLEAR MEDICINE MARKET SIZE, BY RADIOPHARMACEUTICAL THERAPY, 2018-2024 (USD MILLION)
TABLE 182. MEXICO NUCLEAR MEDICINE MARKET SIZE, BY RADIOPHARMACEUTICAL THERAPY, 2025-2030 (USD MILLION)
TABLE 183. MEXICO NUCLEAR MEDICINE MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 184. MEXICO NUCLEAR MEDICINE MARKET SIZE, BY MODE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 185. MEXICO NUCLEAR MEDICINE MARKET SIZE, BY USAGE, 2018-2024 (USD MILLION)
TABLE 186. MEXICO NUCLEAR MEDICINE MARKET SIZE, BY USAGE, 2025-2030 (USD MILLION)
TABLE 187. MEXICO NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC PROCEDURE, 2018-2024 (USD MILLION)
TABLE 188. MEXICO NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC PROCEDURE, 2025-2030 (USD MILLION)
TABLE 189. MEXICO NUCLEAR MEDICINE MARKET SIZE, BY PET SCANNERS, 2018-2024 (USD MILLION)
TABLE 190. MEXICO NUCLEAR MEDICINE MARKET SIZE, BY PET SCANNERS, 2025-2030 (USD MILLION)
TABLE 191. MEXICO NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 192. MEXICO NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 193. MEXICO NUCLEAR MEDICINE MARKET SIZE, BY END USERS, 2018-2024 (USD MILLION)
TABLE 194. MEXICO NUCLEAR MEDICINE MARKET SIZE, BY END USERS, 2025-2030 (USD MILLION)
TABLE 195. MEXICO NUCLEAR MEDICINE MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 196. MEXICO NUCLEAR MEDICINE MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 197. BRAZIL NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 198. BRAZIL NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 199. BRAZIL NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC RADIOPHARMACEUTICALS, 2018-2024 (USD MILLION)
TABLE 200. BRAZIL NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC RADIOPHARMACEUTICALS, 2025-2030 (USD MILLION)
TABLE 201. BRAZIL NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC NUCLEAR MEDICINE, 2018-2024 (USD MILLION)
TABLE 202. BRAZIL NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC NUCLEAR MEDICINE, 2025-2030 (USD MILLION)
TABLE 203. BRAZIL NUCLEAR MEDICINE MARKET SIZE, BY BRACHYTHERAPY ISOTOPES, 2018-2024 (USD MILLION)
TABLE 204. BRAZIL NUCLEAR MEDICINE MARKET SIZE, BY BRACHYTHERAPY ISOTOPES, 2025-2030 (USD MILLION)
TABLE 205. BRAZIL NUCLEAR MEDICINE MARKET SIZE, BY RADIOPHARMACEUTICAL THERAPY, 2018-2024 (USD MILLION)
TABLE 206. BRAZIL NUCLEAR MEDICINE MARKET SIZE, BY RADIOPHARMACEUTICAL THERAPY, 2025-2030 (USD MILLION)
TABLE 207. BRAZIL NUCLEAR MEDICINE MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 208. BRAZIL NUCLEAR MEDICINE MARKET SIZE, BY MODE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 209. BRAZIL NUCLEAR MEDICINE MARKET SIZE, BY USAGE, 2018-2024 (USD MILLION)
TABLE 210. BRAZIL NUCLEAR MEDICINE MARKET SIZE, BY USAGE, 2025-2030 (USD MILLION)
TABLE 211. BRAZIL NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC PROCEDURE, 2018-2024 (USD MILLION)
TABLE 212. BRAZIL NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC PROCEDURE, 2025-2030 (USD MILLION)
TABLE 213. BRAZIL NUCLEAR MEDICINE MARKET SIZE, BY PET SCANNERS, 2018-2024 (USD MILLION)
TABLE 214. BRAZIL NUCLEAR MEDICINE MARKET SIZE, BY PET SCANNERS, 2025-2030 (USD MILLION)
TABLE 215. BRAZIL NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 216. BRAZIL NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 217. BRAZIL NUCLEAR MEDICINE MARKET SIZE, BY END USERS, 2018-2024 (USD MILLION)
TABLE 218. BRAZIL NUCLEAR MEDICINE MARKET SIZE, BY END USERS, 2025-2030 (USD MILLION)
TABLE 219. BRAZIL NUCLEAR MEDICINE MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 220. BRAZIL NUCLEAR MEDICINE MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 221. ARGENTINA NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 222. ARGENTINA NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 223. ARGENTINA NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC RADIOPHARMACEUTICALS, 2018-2024 (USD MILLION)
TABLE 224. ARGENTINA NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC RADIOPHARMACEUTICALS, 2025-2030 (USD MILLION)
TABLE 225. ARGENTINA NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC NUCLEAR MEDICINE, 2018-2024 (USD MILLION)
TABLE 226. ARGENTINA NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC NUCLEAR MEDICINE, 2025-2030 (USD MILLION)
TABLE 227. ARGENTINA NUCLEAR MEDICINE MARKET SIZE, BY BRACHYTHERAPY ISOTOPES, 2018-2024 (USD MILLION)
TABLE 228. ARGENTINA NUCLEAR MEDICINE MARKET SIZE, BY BRACHYTHERAPY ISOTOPES, 2025-2030 (USD MILLION)
TABLE 229. ARGENTINA NUCLEAR MEDICINE MARKET SIZE, BY RADIOPHARMACEUTICAL THERAPY, 2018-2024 (USD MILLION)
TABLE 230. ARGENTINA NUCLEAR MEDICINE MARKET SIZE, BY RADIOPHARMACEUTICAL THERAPY, 2025-2030 (USD MILLION)
TABLE 231. ARGENTINA NUCLEAR MEDICINE MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 232. ARGENTINA NUCLEAR MEDICINE MARKET SIZE, BY MODE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 233. ARGENTINA NUCLEAR MEDICINE MARKET SIZE, BY USAGE, 2018-2024 (USD MILLION)
TABLE 234. ARGENTINA NUCLEAR MEDICINE MARKET SIZE, BY USAGE, 2025-2030 (USD MILLION)
TABLE 235. ARGENTINA NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC PROCEDURE, 2018-2024 (USD MILLION)
TABLE 236. ARGENTINA NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC PROCEDURE, 2025-2030 (USD MILLION)
TABLE 237. ARGENTINA NUCLEAR MEDICINE MARKET SIZE, BY PET SCANNERS, 2018-2024 (USD MILLION)
TABLE 238. ARGENTINA NUCLEAR MEDICINE MARKET SIZE, BY PET SCANNERS, 2025-2030 (USD MILLION)
TABLE 239. ARGENTINA NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 240. ARGENTINA NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 241. ARGENTINA NUCLEAR MEDICINE MARKET SIZE, BY END USERS, 2018-2024 (USD MILLION)
TABLE 242. ARGENTINA NUCLEAR MEDICINE MARKET SIZE, BY END USERS, 2025-2030 (USD MILLION)
TABLE 243. ARGENTINA NUCLEAR MEDICINE MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 244. ARGENTINA NUCLEAR MEDICINE MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 245. EUROPE, MIDDLE EAST & AFRICA NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 246. EUROPE, MIDDLE EAST & AFRICA NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 247. EUROPE, MIDDLE EAST & AFRICA NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC RADIOPHARMACEUTICALS, 2018-2024 (USD MILLION)
TABLE 248. EUROPE, MIDDLE EAST & AFRICA NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC RADIOPHARMACEUTICALS, 2025-2030 (USD MILLION)
TABLE 249. EUROPE, MIDDLE EAST & AFRICA NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC NUCLEAR MEDICINE, 2018-2024 (USD MILLION)
TABLE 250. EUROPE, MIDDLE EAST & AFRICA NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC NUCLEAR MEDICINE, 2025-2030 (USD MILLION)
TABLE 251. EUROPE, MIDDLE EAST & AFRICA NUCLEAR MEDICINE MARKET SIZE, BY BRACHYTHERAPY ISOTOPES, 2018-2024 (USD MILLION)
TABLE 252. EUROPE, MIDDLE EAST & AFRICA NUCLEAR MEDICINE MARKET SIZE, BY BRACHYTHERAPY ISOTOPES, 2025-2030 (USD MILLION)
TABLE 253. EUROPE, MIDDLE EAST & AFRICA NUCLEAR MEDICINE MARKET SIZE, BY RADIOPHARMACEUTICAL THERAPY, 2018-2024 (USD MILLION)
TABLE 254. EUROPE, MIDDLE EAST & AFRICA NUCLEAR MEDICINE MARKET SIZE, BY RADIOPHARMACEUTICAL THERAPY, 2025-2030 (USD MILLION)
TABLE 255. EUROPE, MIDDLE EAST & AFRICA NUCLEAR MEDICINE MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 256. EUROPE, MIDDLE EAST & AFRICA NUCLEAR MEDICINE MARKET SIZE, BY MODE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 257. EUROPE, MIDDLE EAST & AFRICA NUCLEAR MEDICINE MARKET SIZE, BY USAGE, 2018-2024 (USD MILLION)
TABLE 258. EUROPE, MIDDLE EAST & AFRICA NUCLEAR MEDICINE MARKET SIZE, BY USAGE, 2025-2030 (USD MILLION)
TABLE 259. EUROPE, MIDDLE EAST & AFRICA NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC PROCEDURE, 2018-2024 (USD MILLION)
TABLE 260. EUROPE, MIDDLE EAST & AFRICA NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC PROCEDURE, 2025-2030 (USD MILLION)
TABLE 261. EUROPE, MIDDLE EAST & AFRICA NUCLEAR MEDICINE MARKET SIZE, BY PET SCANNERS, 2018-2024 (USD MILLION)
TABLE 262. EUROPE, MIDDLE EAST & AFRICA NUCLEAR MEDICINE MARKET SIZE, BY PET SCANNERS, 2025-2030 (USD MILLION)
TABLE 263. EUROPE, MIDDLE EAST & AFRICA NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 264. EUROPE, MIDDLE EAST & AFRICA NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 265. EUROPE, MIDDLE EAST & AFRICA NUCLEAR MEDICINE MARKET SIZE, BY END USERS, 2018-2024 (USD MILLION)
TABLE 266. EUROPE, MIDDLE EAST & AFRICA NUCLEAR MEDICINE MARKET SIZE, BY END USERS, 2025-2030 (USD MILLION)
TABLE 267. EUROPE, MIDDLE EAST & AFRICA NUCLEAR MEDICINE MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 268. EUROPE, MIDDLE EAST & AFRICA NUCLEAR MEDICINE MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 269. EUROPE, MIDDLE EAST & AFRICA NUCLEAR MEDICINE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 270. EUROPE, MIDDLE EAST & AFRICA NUCLEAR MEDICINE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 271. UNITED KINGDOM NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 272. UNITED KINGDOM NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 273. UNITED KINGDOM NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC RADIOPHARMACEUTICALS, 2018-2024 (USD MILLION)
TABLE 274. UNITED KINGDOM NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC RADIOPHARMACEUTICALS, 2025-2030 (USD MILLION)
TABLE 275. UNITED KINGDOM NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC NUCLEAR MEDICINE, 2018-2024 (USD MILLION)
TABLE 276. UNITED KINGDOM NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC NUCLEAR MEDICINE, 2025-2030 (USD MILLION)
TABLE 277. UNITED KINGDOM NUCLEAR MEDICINE MARKET SIZE, BY BRACHYTHERAPY ISOTOPES, 2018-2024 (USD MILLION)
TABLE 278. UNITED KINGDOM NUCLEAR MEDICINE MARKET SIZE, BY BRACHYTHERAPY ISOTOPES, 2025-2030 (USD MILLION)
TABLE 279. UNITED KINGDOM NUCLEAR MEDICINE MARKET SIZE, BY RADIOPHARMACEUTICAL THERAPY, 2018-2024 (USD MILLION)
TABLE 280. UNITED KINGDOM NUCLEAR MEDICINE MARKET SIZE, BY RADIOPHARMACEUTICAL THERAPY, 2025-2030 (USD MILLION)
TABLE 281. UNITED KINGDOM NUCLEAR MEDICINE MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 282. UNITED KINGDOM NUCLEAR MEDICINE MARKET SIZE, BY MODE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 283. UNITED KINGDOM NUCLEAR MEDICINE MARKET SIZE, BY USAGE, 2018-2024 (USD MILLION)
TABLE 284. UNITED KINGDOM NUCLEAR MEDICINE MARKET SIZE, BY USAGE, 2025-2030 (USD MILLION)
TABLE 285. UNITED KINGDOM NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC PROCEDURE, 2018-2024 (USD MILLION)
TABLE 286. UNITED KINGDOM NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC PROCEDURE, 2025-2030 (USD MILLION)
TABLE 287. UNITED KINGDOM NUCLEAR MEDICINE MARKET SIZE, BY PET SCANNERS, 2018-2024 (USD MILLION)
TABLE 288. UNITED KINGDOM NUCLEAR MEDICINE MARKET SIZE, BY PET SCANNERS, 2025-2030 (USD MILLION)
TABLE 289. UNITED KINGDOM NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 290. UNITED KINGDOM NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 291. UNITED KINGDOM NUCLEAR MEDICINE MARKET SIZE, BY END USERS, 2018-2024 (USD MILLION)
TABLE 292. UNITED KINGDOM NUCLEAR MEDICINE MARKET SIZE, BY END USERS, 2025-2030 (USD MILLION)
TABLE 293. UNITED KINGDOM NUCLEAR MEDICINE MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 294. UNITED KINGDOM NUCLEAR MEDICINE MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 295. GERMANY NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 296. GERMANY NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 297. GERMANY NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC RADIOPHARMACEUTICALS, 2018-2024 (USD MILLION)
TABLE 298. GERMANY NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC RADIOPHARMACEUTICALS, 2025-2030 (USD MILLION)
TABLE 299. GERMANY NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC NUCLEAR MEDICINE, 2018-2024 (USD MILLION)
TABLE 300. GERMANY NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC NUCLEAR MEDICINE, 2025-2030 (USD MILLION)
TABLE 301. GERMANY NUCLEAR MEDICINE MARKET SIZE, BY BRACHYTHERAPY ISOTOPES, 2018-2024 (USD MILLION)
TABLE 302. GERMANY NUCLEAR MEDICINE MARKET SIZE, BY BRACHYTHERAPY ISOTOPES, 2025-2030 (USD MILLION)
TABLE 303. GERMANY NUCLEAR MEDICINE MARKET SIZE, BY RADIOPHARMACEUTICAL THERAPY, 2018-2024 (USD MILLION)
TABLE 304. GERMANY NUCLEAR MEDICINE MARKET SIZE, BY RADIOPHARMACEUTICAL THERAPY, 2025-2030 (USD MILLION)
TABLE 305. GERMANY NUCLEAR MEDICINE MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 306. GERMANY NUCLEAR MEDICINE MARKET SIZE, BY MODE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 307. GERMANY NUCLEAR MEDICINE MARKET SIZE, BY USAGE, 2018-2024 (USD MILLION)
TABLE 308. GERMANY NUCLEAR MEDICINE MARKET SIZE, BY USAGE, 2025-2030 (USD MILLION)
TABLE 309. GERMANY NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC PROCEDURE, 2018-2024 (USD MILLION)
TABLE 310. GERMANY NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC PROCEDURE, 2025-2030 (USD MILLION)
TABLE 311. GERMANY NUCLEAR MEDICINE MARKET SIZE, BY PET SCANNERS, 2018-2024 (USD MILLION)
TABLE 312. GERMANY NUCLEAR MEDICINE MARKET SIZE, BY PET SCANNERS, 2025-2030 (USD MILLION)
TABLE 313. GERMANY NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 314. GERMANY NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 315. GERMANY NUCLEAR MEDICINE MARKET SIZE, BY END USERS, 2018-2024 (USD MILLION)
TABLE 316. GERMANY NUCLEAR MEDICINE MARKET SIZE, BY END USERS, 2025-2030 (USD MILLION)
TABLE 317. GERMANY NUCLEAR MEDICINE MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 318. GERMANY NUCLEAR MEDICINE MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 319. FRANCE NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 320. FRANCE NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 321. FRANCE NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC RADIOPHARMACEUTICALS, 2018-2024 (USD MILLION)
TABLE 322. FRANCE NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC RADIOPHARMACEUTICALS, 2025-2030 (USD MILLION)
TABLE 323. FRANCE NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC NUCLEAR MEDICINE, 2018-2024 (USD MILLION)
TABLE 324. FRANCE NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC NUCLEAR MEDICINE, 2025-2030 (USD MILLION)
TABLE 325. FRANCE NUCLEAR MEDICINE MARKET SIZE, BY BRACHYTHERAPY ISOTOPES, 2018-2024 (USD MILLION)
TABLE 326. FRANCE NUCLEAR MEDICINE MARKET SIZE, BY BRACHYTHERAPY ISOTOPES, 2025-2030 (USD MILLION)
TABLE 327. FRANCE NUCLEAR MEDICINE MARKET SIZE, BY RADIOPHARMACEUTICAL THERAPY, 2018-2024 (USD MILLION)
TABLE 328. FRANCE NUCLEAR MEDICINE MARKET SIZE, BY RADIOPHARMACEUTICAL THERAPY, 2025-2030 (USD MILLION)
TABLE 329. FRANCE NUCLEAR MEDICINE MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 330. FRANCE NUCLEAR MEDICINE MARKET SIZE, BY MODE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 331. FRANCE NUCLEAR MEDICINE MARKET SIZE, BY US

Samples

Loading
LOADING...

Companies Mentioned

  • 3B Pharmaceuticals GmbH
  • Actinium Pharmaceuticals, Inc.
  • B J Madan & Co.
  • Bayer AG
  • Bracco S.p.A.
  • BWX Technologies, Inc.
  • Clarity Pharmaceuticals
  • Curium
  • Eli Lilly and Company
  • GE HealthCare
  • IBA
  • Institute of Isotopes Co., Ltd
  • Isotopia Molecular Imaging Ltd.
  • Jubilant Pharma Limited
  • Lantheus Holdings, Inc.
  • Medi-Radiopharma Co., Ltd.
  • Nordion
  • Northstar Medical Technologies LLC
  • Novartis AG
  • Nusano, Inc.
  • PeptiDream Inc.
  • Radiopharm Theranostics Limited
  • SHINE Technologies, LLC
  • Siemens Healthineers AG
  • Sinotau Pharmaceuticals Group
  • South African Nuclear Energy Corporation
  • State Atomic Energy Corporation Rosatom
  • Thor Medical AS by Nordic Nanovector ASA

Table Information

Report AttributeDetails
No. of Pages181
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 16.05 Billion
Forecasted Market Value ( USD ) by 2030 $ 27.04 Billion
Compound Annual Growth Rate10.8%
Regions CoveredGlobal
No. of Companies Mentioned28

Related Topics

Related Reports

Nuclear Medicine & Radiopharmaceuticals Market by Product Type (Diagnostic Radiopharmaceuticals, Therapeutic Radiopharmaceuticals), Application (Bone Imaging, Cardiology, Inflammation Imaging), End User, Distribution Channel, Isotope Type - Global Forecast 2025-2030 - Product Image

Nuclear Medicine & Radiopharmaceuticals Market by Product Type (Diagnostic Radiopharmaceuticals, Therapeutic Radiopharmaceuticals), Application (Bone Imaging, Cardiology, Inflammation Imaging), End User, Distribution Channel, Isotope Type - Global Forecast 2025-2030

  • Report
  • 194 Pages
  • Global
From
Nuclear Medicine Market Report and Forecast 2025-2034 - Product Image

Nuclear Medicine Market Report and Forecast 2025-2034

  • Report
  • 400 Pages
  • Global
From
Nuclear Medicine Radioisotopes Market by Radiopharmaceuticals (Diagnostic Agents, Therapeutic Agents) - Global Forecast 2025-2030 - Product Image

Nuclear Medicine Radioisotopes Market by Radiopharmaceuticals (Diagnostic Agents, Therapeutic Agents) - Global Forecast 2025-2030

  • Report
  • 189 Pages
  • Global
From
Nuclear Medicine Therapeutics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Image

Nuclear Medicine Therapeutics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • 180 Pages
  • Global
From
Nuclear Medicine Market Report 2025 - Product Image

Nuclear Medicine Market Report 2025

  • Report
  • 200 Pages
  • Global
From

About the Nuclear Medicine Market

Nuclear Medicine is a field of medicine that uses radioactive materials to diagnose and treat diseases, particularly cancer. Nuclear Medicine is used to detect and monitor the progression of cancer, as well as to provide targeted treatments. It is used to detect cancer cells in the body, to measure the effectiveness of cancer treatments, and to provide targeted radiation therapy. Nuclear Medicine can also be used to detect and monitor the spread of cancer to other parts of the body. Nuclear Medicine is used in combination with other treatments, such as chemotherapy and surgery, to provide a comprehensive approach to cancer care. It is also used to provide palliative care, to reduce pain and improve quality of life for cancer patients. Nuclear Medicine is a rapidly growing field, with new technologies and treatments being developed to improve the diagnosis and treatment of cancer. Companies in the Nuclear Medicine market include GE Healthcare, Siemens Healthineers, Philips Healthcare, and Toshiba Medical Systems. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.